TPG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$676K Hold
584
– – 0.36% 52
2026
Q2
$700K Buy
584
+9
+2% +$9.2K 0.38% 51
2026
Q1
$529K Buy
575
+16
+3% +$16.2K 0.33% 56
2025
Q4
$601K Hold
559
– – 0.37% 45
2025
Q3
$427K Sell
559
-1
-0.2% -$744 0.28% 60
2025
Q2
$437K Hold
560
– – 0.32% 53
2025
Q1
$463K Sell
560
-40
-7% -$33.3K 0.36% 44
2024
Q4
$463K Sell
600
-1
-0.2% -$828 0.36% 45
2024
Q3
$532K Hold
601
– – 0.42% 42
2024
Q2
$544K Buy
+601
New +$481K 0.46% 42

Other funds holding LLY

TPG Advisors's LLY Position: Q3 2026 in Review

TPG Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 584 shares worth $676K. The position accounts for 0.36% of the portfolio, ranked #52.

TPG Advisors first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $700K in Q2 2026. 1,047 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • TPG Advisors held 584 shares of Eli Lilly worth $676K as of Q3 2026.
  • TPG Advisors left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.36% of TPG Advisors's portfolio in Q3 2026, its #52 holding.
  • TPG Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • TPG Advisors's Eli Lilly position peaked at $700K in Q2 2026.
  • 1,047 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TPG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.